
Fig. 1.
Uricase activity of the selected strains based on the clear zone formation around colonies on the uric acid-supplemented (0.3%) BT agar.
Table I
Screening and partial characterization of uricase-producing isolates.
| Isolate code | Source of strains | Motility | Sporulation | Gram test | Uricase activity (mm) | |
|---|---|---|---|---|---|---|
| Gram stain | KOH test | |||||
| UR1 | Soil | – | + | + | – | 75 |
| UR2 | Soil | – | + | + | – | 74 |
| UR3 | Poultry wastes | – | + | + | – | 73 |
| UR4 | Poultry wastes | – | + | + | – | 70 |
| UR5 | Poultry wastes | – | + | + | – | 70 |
| UR6 | Soil | – | + | + | – | 70 |
| UR7 | Soil | – | + | + | – | 70 |
| UR8 | Poultry wastes | – | + | + | – | 70 |
| UR9 | Poultry wastes | – | + | + | – | 70 |
| UR10 | Poultry wastes | – | + | + | – | 70 |
| UR11 | Poultry wastes | – | + | + | – | 70 |
| UR12 | Poultry wastes | – | + | + | – | 70 |
| UR13 | Poultry wastes | – | + | + | – | 68 |
| UR14 | Poultry wastes | – | + | + | – | 68 |
| UR15 | Soil | – | + | + | – | 67 |
| UR16 | Poultry wastes | – | + | + | – | 66 |
| UR17 | Poultry wastes | – | + | + | – | 65 |
| UR18 | Poultry wastes | – | + | + | – | 65 |
| UR19 | Poultry wastes | – | + | + | – | 65 |
| UR20 | Poultry wastes | – | + | + | – | 65 |
| UR21 | Poultry wastes | – | + | + | – | 65 |
| UR22 | Poultry wastes | – | + | + | – | 65 |
| UR23 | Poultry wastes | – | + | + | – | 65 |
| UR24 | Soil | – | + | + | – | 62 |
| UR25 | Poultry wastes | – | + | + | – | 60 |
| UR26 | Poultry wastes | – | + | + | – | 60 |
| UR27 | Poultry wastes | – | + | + | – | 60 |
| UR28 | Soil | – | + | + | – | 60 |
| UR29 | Poultry wastes | – | + | + | – | 60 |
| UR30 | Poultry wastes | – | + | + | – | 60 |
| UR31 | Poultry wastes | – | + | + | – | 60 |
| UR32 | Poultry wastes | – | + | + | – | 60 |
| UR33 | Poultry wastes | – | + | + | – | 60 |
| UR34 | Poultry wastes | – | + | + | – | 60 |
| UR35 | Poultry wastes | – | + | + | – | 60 |
| UR36 | Poultry wastes | – | + | + | – | 60 |
| UR37 | Poultry wastes | – | + | + | – | 60 |
| UR38 | Poultry wastes | – | + | + | – | 55 |
| UR39 | Poultry wastes | – | + | + | – | 55 |
| UR40 | Poultry wastes | – | + | + | – | 55 |
| UR41 | Poultry wastes | – | + | + | – | 55 |
| UR42 | Poultry wastes | – | + | + | – | 55 |
| UR43 | Poultry wastes | – | + | + | – | 50 |
| UR44 | Poultry wastes | – | + | + | – | 50 |
| UR45 | Poultry wastes | – | + | + | – | 50 |
| UR46 | Poultry wastes | – | + | + | – | 50 |
| UR47 | Poultry wastes | – | + | + | – | 50 |
| UR48 | Poultry wastes | – | + | + | – | 45 |
| UR49 | Soil | – | + | + | – | 45 |
| UR50 | Poultry wastes | – | + | + | – | 45 |
| UR51 | Soil | – | + | + | – | 40 |
| UR52 | Soil | – | + | + | – | 40 |
1 Uric acid degrading bacteria were enriched in uric acid-supplemented (0.8%) enrichment broth followed by incubation for 48 h at 37°C under shaking conditions. Uric acid turbidity gradually disappeared during fermentation. Then, dilutions of enrichment cultures were inoculated on uric acid-supplemented (0.3%) BT agar plates where all the isolates formed clear zones.
Table II
Morphological and partial characterization of uricase-producing isolates.
| Characteristics | Most promising uricase-producing isolates | ||||
|---|---|---|---|---|---|
| UR1 | UR2 | UR5 | UR6 | UR10 | |
| Colony morphology: | |||||
| Form | Irregular | Irregular | Irregular | Irregular | Irregular |
| Color on NA | whitish | Whitish | Whitish | Whitish | Whitish |
| Pigment | – | – | – | – | – |
| Elevation | Flat | Flat | Flat | Flat | Flat |
| Opacity | Opaque | Opaque | Opaque | Opaque | Opaque |
| Consistency | Dry | Dry | Dry | Dry | Dry |
| Cell morphology: | |||||
| Shape | Rods shaped | Rods shaped | Rods shaped | Rods shaped | Rods shaped |
| Gram stain | – | – | – | – | – |
| Catalase | + | + | + | + | + |
| Oxidase | + | + | + | + | + |
| Sporulation | + | + | + | + | + |
| Motility | + | + | + | + | + |
| Carbon source utilization: | |||||
| Maltose | +\– | + | + | + | + |
| Dextrose | + | + | + | + | + |
| Fructose | + | + | + | + | + |
| D-Glucose | + | + | + | + | + |
| Sucrose | + | + | + | + | + |
| Nitrogen source utilization: | |||||
| Casein | + | + | + | + | + |
| Yeast extract | + | + | + | + | + |
| Urea | + | + | + | + | + |
| Growth on NaCl (%): | |||||
| 0 | + | + | + | + | + |
| 1% | + | + | + | + | + |
| 2% | +\– | +\– | +\– | +\– | +\– |
| 5% | – | +\– | +\– | +\– | +\– |
| 10% | – | – | – | – | – |
| pH optimum: | |||||
| 5 | + | +\– | +\– | +\– | +\– |
| 6 | + | +\– | +\– | +\– | +\– |
| 7 | + | + | + | + | + |
| 8 | + | + | + | + | + |
| 9 | +\– | +\– | +\– | +\– | +\– |
| Temperature optimum: | |||||
| 20°C | +\– | +\– | – | +\– | +\– |
| 30°C | + | + | + | + | + |
| 37°C | + | + | + | + | + |
| 40°C | + | + | + | + | + |
| 50°C | – | – | – | – | – |
| MacConkey agar: | – | – | – | – | – |
| Blood agar hemolysis | α-hemolytic | α-hemolytic | α-hemolytic | α-hemolytic | α-hemolytic |
| Enzyme secretion: | |||||
| Uricase | + | + | + | + | + |
| Urease | + | + | + | + | + |
| Protease | – | – | – | – | – |
| Amylase | – | – | – | – | – |
| Lipase | – | – | – | – | – |
| Cellulose | + | + | + | + | + |
Table III
API-20E profile of sugar fermentation and enzyme activity of uricase-producing isolates.
| Biochemical test | Uricase-producing isolates | Reference strain | |||||
|---|---|---|---|---|---|---|---|
| UR1 | UR2 | UR5 | UR6 | UR10 | Alcaligenes faecalis DSM13644 | ||
| 1 | O-nitrophenyl-b D-galactopyranoside (ONPG) | – | – | – | – | – | – |
| 2 | Arginine dihydrolase (ADH) | – | – | – | – | – | – |
| 3 | Lysine decarboxylase (LDC) | – | – | – | – | – | – |
| 4 | Ornithine decarboxylase (ODC) | – | – | – | – | – | – |
| 5 | Citrate (CIT) | + | + | + | + | + | + |
| 6 | Hydrogen sulfide (H2S) | – | – | – | – | – | + |
| 7 | Urease (URA) | + | + | + | + | + | – |
| 8 | Tryptophan deaminase (TDA) | – | – | – | – | – | + |
| 9 | Indole (IND) | – | – | – | – | – | + |
| 10 | Voges-Proskauer test (VP) | + | – | + | + | + | + |
| 11 | Gelatinase (GEL) | – | – | – | – | – | – |
| Sugar fermentation: | |||||||
| 12 | Glucose (GLU) | + | + | + | + | + | + |
| 13 | Mannose (MAN) | – | – | – | – | – | – |
| 14 | Inositol (INO) | – | – | – | – | – | – |
| 15 | Sorbitol (SOR) | – | – | – | – | – | – |
| 16 | Rhamnose (RHA) | – | – | – | – | – | – |
| 17 | Sucrose (SAC) | + | + | + | + | + | + |
| 18 | Melibiose (MEL) | – | – | – | – | – | – |
| 19 | Amygdalin (AMY) | – | – | – | – | – | – |
| 20 | Arabinose (ARA) | – | – | – | – | – | – |
Table IV
bioMérieux VITEK®-based biochemical tests of uricase-producing isolates.
| Carbon source utilization, enzymatic activities and resistance | Conc. (mg) | Uricase isolates/identification results | |||||
|---|---|---|---|---|---|---|---|
| UR1 | UR2 | UR5 | UR6 | UR10 | |||
| 1 | Ala-Phe-Pro-arylamidase (APPA) | 0.0384 | – | – | – | – | – |
| 2 | Adonitol (ADO) | 0.1875 | – | – | – | – | – |
| 3 | L-Pyrrolydonyl-arylamidase (PyrA) | 0.018 | – | – | – | – | – |
| 4 | L-Arabitol (lARL) | 0.3 | – | – | – | – | – |
| 5 | D-Cellobiose (dCEL) | 0.3 | – | – | – | – | – |
| 6 | β-Galactosidase (BGAL) | 0.036 | – | – | – | – | – |
| 7 | Production (H2S) | 0.0024 | – | – | – | – | – |
| 8 | β-N-acetyl-glucosaminidase (BNAG) | 0.0408 | – | – | – | – | – |
| 9 | Glutamyl arylamidase pNA (AGLTp) | 0.0324 | – | – | – | – | – |
| 10 | D-Glucose (dGLU) | 0.3 | + | + | + | + | + |
| 11 | γ-Glutamyl-transferase (GGT) | 0.0228 | – | – | – | – | – |
| 12 | Fermentation/glucose (OFF) | 0.45 | + | + | + | + | + |
| 13 | β-Glucosidase (BGLU) | 0.036 | – | – | – | – | – |
| 14 | D-Maltose (dMAL) | 0.3 | – | – | – | – | – |
| 15 | D-Mannitol (dMAN) | 0.1875 | – | – | – | – | – |
| 16 | D-Mannose (dMNE) | 0.3 | – | – | – | – | – |
| 17 | β-Xylosidase (BXYL) | 0.0324 | – | – | – | – | – |
| 18 | β-Alanine arylamidase pNA (BAlap) | 0.0174 | – | – | – | – | – |
| 19 | L-Proline arylamidase (ProA) | 0.0234 | + | + | + | + | + |
| 20 | Lipase (LIP) | 0.0192 | – | – | – | – | – |
| 21 | Palationse (PLE) | 0.3 | – | – | – | – | – |
| 22 | Tyrosine arylamidase (TyrA) | 0.0276 | + | + | + | + | + |
| 23 | Urease (URE) | 0.15 | + | + | – | + | + |
| 24 | D-Sorbitol (dSOR) | 0.1875 | – | – | – | – | – |
| 25 | Saccharose/sucrose (SAC) | 0.3 | – | – | – | – | – |
| 26 | D-Tagatose (dTAG) | 0.3 | – | – | – | – | – |
| 27 | D-Trehalose (dTRE) | 0.3 | – | – | – | – | – |
| 28 | Citrate (sodium) (CIT) | 0.054 | – | – | + | – | – |
| 29 | Malonate (MNT) | 0.15 | – | – | + | – | – |
| 30 | 5-Keto-D-gluconate (5KG) | 0.3 | – | – | – | – | – |
| 31 | L-Lactate alkalinisation (ILATk) | 0.15 | + | + | + | + | + |
| 32 | α-Glucosidase (AGLU) | 0.036 | – | – | – | – | – |
| 33 | Succinate alkalinisation (SUCT) | 0.15 | – | – | + | + | – |
| 34 | β-N-acetyl-galactosaminidase (NAGA) | 0.0306 | – | – | – | – | – |
| 35 | α-Galactosidase (AGAL) | 0.036 | – | – | – | – | – |
| 36 | Phosphatase (PHOS) | 0.0504 | – | – | – | – | – |
| 37 | Glycine arylamidase (GlyA) | 0.012 | – | – | – | – | – |
| 38 | Ornithine decarboxylase (ODC) | 0.3 | – | – | – | – | – |
| 39 | Lysine decarboxylase (LDC) | 0.15 | – | – | – | – | – |
| 40 | L-Histidine assimilation (IHISa) | 0.087 | -\+ | – | – | + | +\- |
| 41 | Coumarate (CMT) | 0.126 | + | – | – | – | – |
| 42 | β-Glucoronidase (BGUR) | 0.0378 | – | – | – | – | – |
| 43 | O/129 Resistance (comp.vibrio.) (O129R) | 0.0105 | – | – | – | – | – |
| 44 | Glu-Gly-Arg-arylamidase (GGAA) | 0.0576 | – | – | – | – | – |
| 45 | L-malate assimilation (IMLTa) | 0.042 | -\+ | +\- | + | – | – |
| 46 | Ellman (ELLM) | 0.03 | -\+ | -\+ | – | + | – |
| Identification and similarity according to VITEK® data base | Pseudomonas oleovorans (95%) | Pseudomonas oleovorans (95%) | Alcaligenes faecalis (97%) | Acinetobacter lwoffii (92%) | Acinetobacter lwoffii (96%) | ||
Table V
Antibiotic susceptibility of uricase-producing promising isolates.
| Antibiotics | Antibiotics/Disc potency | Uricase-producing isolates | ||||
|---|---|---|---|---|---|---|
| UR1 | UR2 | UR5 | UR6 | UR10 | ||
| Amikacin | 30 μg (AK) | R | R | S | R | S |
| Gentamicin | 10 μg (GM) | S | S | S | S | R |
| Tetracycline | 30 μg (T) | S | S | S | S | S |
| Aztreonam | 30 μg (ATM) | R | R | R | R | R |
| Ciprofloxacin | 5 μg (CIP) | S | S | R | S | S |
| Cefotaxime | 30 μg (Cf) | S | S | R | R | R |
| Ceftazidime | 30 μg (CAZ) | S | R | S | R | S |
| Cefepime | 30 μg (CPM) | R | R | S | R | R |
| Imipenem | 10 μg (IMI) | S | S | S | S | S |
| Piperacillin | 100 μg (PRL) | S | S | R | R | S |
| Trimethoprim/sulfamethoxazole | 25 μg (TS) | S | S | R | S | R |
| Chloramphenicol | 30 μg (C) | S | S | S | S | S |
Table VI
16S rRNA gene sequence-based molecular identification of uricase-producing promising strains.
| Isolate code | Blast match | Gene Bank Accession No. | 16S rRNA Identity (%) |
|---|---|---|---|
| Strain UR1 (PP563675) | – Alcaligenes faecalis strain NBRC 13111 | – NR_113606.1 | 96.96 |
| – Alcaligenes ammonioxydans strain HO-1 | – NR_180910.1 | 96.86 | |
| – Alcaligenes aquatilis strain LMG 22996 | – NR_104977.1 | 96.54 | |
| – Alcaligenes endophyticus strain AER10 | – NR_156855.1 | 95.91 | |
| – Alcaligenes pakistanensis strain NCCP-650 | – NR_145932.1 | 95.58 | |
| Strain UR2 (PP563676) | – Alcaligenes faecalis strain NBRC 13111 | – NR_113606.1 | 95.40 |
| – Alcaligenes ammonioxydans strain HO-1 | – NR_180910.1 | 95.19 | |
| – Alcaligenes aquatilis strain LMG 22996 | – NR_156855.1 | 94.97 | |
| – Alcaligenes endophyticus strain AER10 | – NR_156855.1 | 95.15 | |
| – Alcaligenes pakistanensis strain NCCP-650 | – NR_145932.1 | 93.79 | |
| Strain UR5 (PP563677) | – Alcaligenes ammonioxydans strain HO-1 | – NR_180910.1 | 97.28 |
| – Alcaligenes faecalis strain NBRC 13111 | – NR_113606.1 | 97.20 | |
| – Alcaligenes aquatilis strain LMG 22996 | – NR_104977.1 | 96.89 | |
| – Alcaligenes pakistanensis strain NCCP-650 | – NR_145932.1 | 96.11 | |
| – Alcaligenes endophyticus strain AER10 | – NR_156855. | 95.96 | |
| Strain UR6 (PP563678) | – Alcaligenes ammonioxydans strain HO-1 16S | – NR_180910.1 | 98.77 |
| – Alcaligenes faecalis strain NBRC 13111 16S | – NR_113606.1 | 98.56 | |
| – Alcaligenes aquatilis strain LMG 22996 | – NR_104977.1 | 98.15 | |
| – Alcaligenes endophyticus strain AER10 | – NR_156855.1 | 98.15 | |
| – Alcaligenes pakistanensis strain NCCP-650 | – NR_145932.1 | 98.15 | |
| Strain UR10 (PP563679) | – Alcaligenes ammonioxydans strain HO-1 | – NR_180910.1 | 98.84 |
| – Alcaligenes faecalis strain NBRC 13111 | – NR_113606.1 | 98.02 | |
| – Alcaligenes aquatilis strain LMG 22996 | – NR_104977.1 | 97.73 | |
| – Alcaligenes pakistanensis strain NCCP-650 | – NR_145932.1 | 96.98 | |
| – Alcaligenes faecalis subsp. phenolicus | – NR_042830.1 | 95.87 |

Fig. 2.
Phylogenetic tree of uricase-producing isolates (shown in blue) and closely related strains of genus Alcaligenes. Bootstrap values out of 100 are mentioned at the nodes. Escherichia coli strain ATCC® 35218™ (J01859.1) and Bacillus subtilis strain: ATCC® 21331™ (AB018487.1) served as the out-group.

Fig. 3.
Effect of incubation period on the growth (OD) and uricase secretion of strain UR1

Fig. 4.
Effect of temperature on the growth (OD) and uricase activity (U/ml) of strain UR1.

Fig. 5.
Effect of pH on the growth (OD) and uricase activity (U/ml) of strain UR1.

Fig. 6.
Impact of carbon and nitrogen sources on strain UR1 growth and uricase activity (U/ml).

Fig. 7.
Impact of different NaCl (%) concentrations on strain UR1 growth (OD) and uricase activity (U/ml).

Fig. 8.
Uricase purification from strain UR1 by gel filtration. Uricase activity exhibiting fractions (F7-F12).
Table VII
Gel-filtration-based uricase purification steps from strain UR1.
| Purification steps | Volume (ml) | Uricase activity (U/ml) | Total uricase activity (U) | Protein concentration (mg/ml) | Specific activity (U/mg) | Purification (fold) | Yield (%) |
|---|---|---|---|---|---|---|---|
| Crude enzyme (10 fold concentration) | 100 | 75 | 7,500 | 5.4 | 13.8 | 1 | 100 |
| Dialysis after ammonium sulfate precipitation | 5 | 112 | 560 | 3.8 | 29.74 | 2.13 | 7.40 |
| Gel filtration (Sephadex) | 5 | 275 | 1,375 | 0.3 | 916 | 66.73 | 18.33 |

Fig. 9.
SDS-PAGE of the purified uricase from strain UR1.
SDS-denatured samples (20–40 μl) were separated in an SDS-polyacrylamide gel (12%) and stained with Serva blue R. Lane 1: molecular mass standard, Lane 2: protein (10 μg) of purified enzyme.

Fig. 10.
Effect of temperature on a) uricase activity, and b) stability.

Fig. 11.
Effect of pH on the uricase activity of strain UR1.

Fig. 12.
Effect of substrate concentration on uricase activity of strain UR1.

Fig. 13.
Effect of the metal ions and inhibitors on uricase activity of strain UR1.